EMCDDA initial report on the new psychoactive substance N,N-diethyl-2-[[4-(1-methylethoxy)phenyl]methyl]-5-nitro-1H-benzimidazole-1-ethanamine (isotonitazene) Summary Isotonitazene is a synthetic opioid analgesic monitored by the EMCDDA as a new...

Psychedelic Medicine - Hacking Psychiatry?! (Video) Psychedelic Therapy as a fundamentally new approach to mental health issues Psychedelic research constitutes a challenge to the current paradigm of mental healthcare. But what makes it so differ...

UNODC. Current NPS Threats – Volume II (January 2020) UNODC Early Warning Advisory Toxicology Highlights Poly-drug use continues to feature highly in cases of fatalities associated with NPS. Benzodiazepine-type NPS are increasingly reported in...

New psychoactive substances (NPS) in the Netherlands: occurrence in forensic drug samples, consumer drug samples and poisons center exposures between 2013 and 2017. Hondebrink, L., Nugteren‐van Lonkhuyzen, J. J., Hunault, C. C., van den Berg, J.,...

USA. Johns Hopkins Scientists Give Psychedelics the Serious Treatment The first research center of its kind in the country is bringing renewed rigor to the investigation of the drugs’ therapeutic uses. (Scientific American, USA, 16.01.2020) http...

New psychoactive substances: concerted efforts and common legislative answers for stemming a growing health hazard. Zaami S. Eur Rev Med Pharmacol Sci. 2019 Nov;23(22):9681-9690. doi: 10.26355/eurrev_201911_19529. https://www.europeanreview.org...